Lisa Thomas | Authors


Detection of Novel “Designer Drugs” Using Full-Scan GC–HRAM

Novel psychoactive substances pose a major challenge for forensic toxicology and drug-seizure laboratories because of the scale and speed at which these new “designer drugs” are entering the market. To keep pace with the threat, laboratories require robust full-scan detection techniques capable of both targeted drug screening and the identification of unexpected compounds too. Here, a full-scan gas chromatography (GC) coupled to high-resolution accurate mass (HRAM) approach for the profiling of known and unknown drugs of abuse is presented.